UK Investment Guides Loader
trending now

Please scroll down to view and accept privacy policy to continue

OUR PRIVACY AND COOKIE POLICY

This Privacy and Cookie Policy states what we will do with your Personal Data once you have submitted your details to the site. By submitting your details, you agree to the principles of this policy. We comply with the Data Protection Act 1998. Any information you give to UK Investment Guides will be held with the utmost care and will not be used in ways that you have not consented to. If you have any requests concerning your personal information or any queries with regard to these practices please contact our Data Manager via email: info@ukinvestmentguides.com

Collection of Information

We collect personal information in a number of different ways. These include email enquiry forms which can be found on our contact us page, through data capture forms found on guide or report download pages and through cookies. You can find out more about what cookies are and why we use them further down this document.

Use of Personal Information

Your personal data will be used by UK Investment Guides to communicate with you. This will take the form of emailing you our product newsletters, sending you specially selected Third Party advertising offers, or communicating with you regarding our service so long as you have opted-in to receiving any of the former. Your personal information will not be used for any purpose not directly related to UK Investment Guides business offering. At any point you can unsubscribe from any or all of our communications by clicking the unsubscribe link which we make available on all our communications. If you have problems doing this you can contact us on 020 3674 7958 and ask to speak with our Data Manager or email info@ukinvestmentguides.com

Data Capture Forms

We will send you information according to the preferences you submitted via our data capture form. If you would like to change these preferences at any point, please email us at info@ukinvestmentguides.com or call us on 020 3674 7958. Alternatively, you can also write to us: Data Manager, 11A, Challenge House, 616 Mitcham Road, Croydon, CR0 3AA

Marketing

On occasion we may market to you products and services related to UK Investment Guides business offering (including updates to our service offering) and also offers from carefully selected advertisers where you have opted-in to receiving such communications. If at any point you would like to opt-out of receiving communications from us, or you would like to change the channels that we use to contact you, please contact us at info@ukinvestmentguides.com. Additionally, you can unsubscribe from any or all of our communications by clicking the unsubscribe link that is available on all of our communications.

Please note that we can only unsubscribe e-mail addresses we know about and not any forwarding or linked addresses from whose accounts a request may be received. To ensure you stop receiving our e-mails, please provide the original e-mail address you signed up with or all addresses you think we may hold.

Other Websites

Our website may contain links to other websites that are outside our control and are not covered by this Privacy Policy. If you access other sites using the links provided, the operators of these sites may collect information from you that will be used by them in accordance with their privacy policies which may differ from ours.

Subject Access Requests

You have the right to see what personal data we hold about you. To obtain a copy of the personal information that we hold about you, please write to us: please email us at info@ukinvestmentguides.com . Alternatively, you can also write to us: Data Manager, 11A, Challenge House, 616 Mitcham Road, Croydon, CR0 3AA.

Internet-based Transfers

Given that the Internet is a global environment, using it to collect and process personal data necessarily involves the transmission of data on an international scale. This means, for instance, that data you pass to us may be processed outside the European Economic Area, although the data will always be held securely and in-line with the requirements of UK data protection legislation. By communicating electronically with us, you acknowledge and consent to our processing of personal data in this way.

Amendments

Please note that this privacy policy is subject to change from time to time. It was last updated in April 2017.

I agree with UK Investment Guides Privacy Policy:  

Glenmark Life Sciences to launch IPO in July

written by Bella Palmer
glenmark

The company intends to use the proceeds from the IPO for capital expenditure requirements which includes the expansion of capacity at the Dahej manufacturing site

Glenmark Life Sciences, the developer and manufacturer of commoditized active pharmaceutical ingredients in chronic therapeutic areas, will launch its initial public offering (IPO) for subscription in the coming week.

It has priced its IPO between Rs 695 and Rs 720 per equity share. The company has reduced its offer size by nearly Rs 150 crore.

When filing the draft red herring prospectus (DRHP), the company was planning to raise Rs 1,160 crore as fresh capital, and promoters were planning to sell 7.3 million shares.

The IPO now consists of a fresh issue of Rs 1,060 crore and an offer for sale of 6.3 million shares worth Rs 453.60 crore.

Kotak Mahindra Capital Company Limited, BofA Securities India Limited and Goldman Sachs (India) Securities Private Limited are the Global Co-ordinators and Book Running Lead Managers to the Offer. DAM Capital Advisors Limited, BOB Capital Markets Limited and SBI Capital Markets Limited are the Book Running Lead Managers to the Offer.

The IP0 will begin on July 27 and conclude on July 29. The anchor investor bid will start on July 26, and it may get listed on exchanges on August 6. The subscription for the IPO will start on July 27 and close on July 29. It has set a price band of Rs695 to Rs720.

At the upper end of the price band, the company could raise to Rs 1,513.60 crore. The offer for sale is made by the company's promoter, Glenmark Pharmaceuticals.

The company intends to use the proceeds from the IPO for capital expenditure requirements which includes the expansion of capacity at the Dahej (Gujarat) manufacturing site to meet the anticipated future demand of its generic active pharmaceutical ingredients (API) products.

Active pharmaceutical ingredient (API) means the active ingredient, which is contained in a medicine.

CEO of Glenmark Life Sciences, Yasir Rajwee said: Except for one antimalarial product segment, our demand outlook I mean demand that we are getting from customers from the last five quarters has been extremely solid. See no one is saying that we are buying less from China and more from India, but it is very clear to see that kind of demand. So I believe China Plus One is a real thing.

Disclaimer:

The opinions expressed by our writers are their own and do not represent the views of UK Investment Guides. The information provided on UK Investment Guides is intended for informational purposes only. UK Investment Guides is not liable for any financial losses incurred. Conduct your own research by contacting financial experts before making any investment decisions.

Share this post with friends!

Related Posts